Skip to main content

Market Overview

Biolase Stock Jumps On Q1 Earnings Beat, Strong Demand For Dental Lasers, Q2 Outlook

Share:
Biolase Stock Jumps On Q1 Earnings Beat, Strong Demand For Dental Lasers, Q2 Outlook
  • Biolase Inc (NASDAQ: BIOLreported a Q1 EPS loss of $(0.06), which missed the analyst consensus of $(0.05) loss, though it improved from a loss of $0.19 reported a year ago.
  • Net revenue of $8.1 million beat the analyst consensus of $7.79 million and increase 70% Y/Y as Q1 2020 was impacted by the COVID-19 pandemic.
  • U.S. laser revenue of $2.9 million increased 200% Y/Y, consumables and other revenue increased 50% Y/Y.
  • International laser revenue increased 84% to $2.0 million, and consumables and other revenue were up 61%. Laser system sales increased 139% Y/Y.
  • The gross margin expanded to 34% from 29% last year, reflecting the impact of the increase in revenues from the COVID-19 pandemic and increased average selling prices for products sold in the U.S.
  • The company ended the quarter with $40.8 million in cash and cash equivalents.
  • Guidance: Biolase sees Q2 sales of $7.5 million - $8.5 million versus the consensus of $8.28 million.
  • Price Action: BIOL shares jump 29.3% at 0.75 during the premarket session on the last check Friday.
 

Related Articles (BIOL)

View Comments and Join the Discussion!

Posted-In: BriefsEarnings News Penny Stocks Guidance Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com